NCBP2AS2

Across TCGA pan-cancer cohorts, NCBP2AS2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated NCBP2AS2 data layer compared with 4 for mass-spec protein.

The strongest signal is observed in uveal melanoma (UVM), where higher NCBP2AS2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated NCBP2AS2 expression acts as an unfavorable survival marker, although some lineages such as UVM and LUSC show a favorable association.

UVM, LIHC, and KIRC are the cancer types where NCBP2AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.809	0.401	<.001	71	view →
LIHC	OS	Tertile	All	0.589	0.770	<.001	65	view →
KIRC	DFS	Tertile	II,III,IV	0.693	0.910	<.001	46	view →
LUSC	OS	Tertile	All	0.827	0.676	<.001	36	view →
UCEC	DFS	Median	All	0.798	0.876	.004	32	view →
SKCM	OS	Quartile	III,IV	0.610	0.853	<.001	28	view →
ACC	DFS	Quartile	All	0.126	0.769	<.001	27	view →
UCS	DFS	Tertile	IV	0.403	0.942	.024	24	view →
STAD	DFS	Tertile	All	0.537	0.235	.007	19	view →
CESC	OS	Quartile	III,IV	0.948	0.731	.018	18	view →
PRAD	DFS	Quartile	All	0.689	0.889	.010	18	view →
KIRP	OS	Median	II,III,IV	0.902	0.734	.010	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

NCBP2AS2–UVM (DFS)

Open the UVM breakdown →